Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

NCT04667143 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

760

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Retagliptin, Henagliflozein, metformin XR

Sponsor

Jiangsu HengRui Medicine Co., Ltd.